研究者情報   
   検索ページ


    (最終更新日:2018-01-18 16:40:09)
  ツダ タカシ   TSUDA TAKASHI
  津田享志
   所属   医学部医学科 臨床腫瘍学
   職種   講師
■ 学術雑誌
1. 原著  Early morphological change for predicting outcome in metastatic
colorectal cancer after regorafenib 2017/12
2. 原著  Exploration of time points and cut-off values for early tumour shrinkage to predict survival outcomes of patients with metastatic colorecatal cancer treated with first-line chemotherapy using a biexponential model for change in tumour size. 2017/11
3. 総説  Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy 2017/09
4. 総説  免疫チェックポイント阻害薬 副作用対策チームの実践 2017/09
5. 原著  Identification of FGFR3-TACC3 fusion in esophageal cancer 2017/02
全件表示(29件)
■ 学会発表
1. Clinical Implication of Morphological Changes of Ramucirumab in Metastatic Gastric Cancer  2017/07/27
2. Identification of a FGFR3-TACC3 fusion in esophageal cancer  2017/04/01
3. "Randomized phase II study of panitumumab (Pmab) plus irinotecan (CPT-11) versus cetuximab (Cmab) plus CPT-11 in patients
with KRAS wild-type (WT) metastatic colorectal cancer (mCRC) following treatment with fluoropyrimidine, CPT-11, and
oxaliplatin (L-OHP) chemotherapy: WJOG6510G."  2017/01
4. Predictability of survival outcome by early tumor shrinkage (ETS) at 8 weeks with cutoff value of 20% in metastatic colorectal cancer (mCRC) patients treated with mFOLFOX6 plus bevacizumab (bev) or FOLFIRI plus bev as first-line chemotherapy (1st-CTx): validation in the phase III WJOG4407G trial  2017/01
5. 当院のIO副作用対策チームの取り組み (シンポジウム・ワークショップ・パネルディスカッション等) 2016/07/29
全件表示(34件)